A comparative study of MMP-2 in vulvar neoplasms

Gynecologic Oncology

Volumn 93, Issue 2, 2004, Pages 454-457

  Bovo, Adriane Cristina ^a,b   Guerreiro Da Silva, Ismael Dale Cotrim ^a   Takita, Luiz Carlos ^a   Fochi, José ^a   Stávale, João Norberto ^a   Marks, Guido ^a   De Lima, Geraldo Rodrigues ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Cancer; Matrix metalloproteinases; Matrix metalloproteinases 2; MMP 2; Vulva; Vulvar diseases; Vulvar neoplasm

Indexed keywords

GELATINASE A; MONOCLONAL ANTIBODY;

ANTIGENICITY; ARTICLE; CANCER INVASION; CELL COUNT; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LICHEN SCLEROSUS ET ATROPHICUS; PATIENT SELECTION; PRIORITY JOURNAL; SCORING SYSTEM; STATISTICAL ANALYSIS; STROMA CELL; UTERINE CERVIX CARCINOMA IN SITU; VULVA TUMOR;

CYTOPLASMIC GRANULES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LICHEN SCLEROSUS ET ATROPHICUS; MATRIX METALLOPROTEINASE 2; PARAFFIN EMBEDDING; REFERENCE VALUES; STROMAL CELLS; VULVA; VULVAR DISEASES; VULVAR NEOPLASMS;

EID: 1942540610     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.01.049     Document Type: Article

References (26)

1. Fox H., Wells M. Recent advances in the pathology of the vulva. Histopathology. 42(3):2003 (Mar);209-216.
2. Chambers A.F., Matrisian L.M. Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst. 89(17):1997 (Sep 3);1260-1270.
3. Jones J.L., Walker R.A. Control of matrix metalloproteinase activity in cancer. J. Pathol. 183(4):1997 (Dec);377-379.
4. Zaki I., Dalziel K.L., Solomonsz F.A., Stevens A. The under-reporting of skin disease in association with squamous cell carcinoma of the vulva. Clin. Exp. Dermatol. 21(5):1996 (Sep);334-337.
5. Sturgeon S.R., Brinton L.A., Devesa S.S., Kurman R.J. In situ and invasive vulvar cancer incidence trends (1973 to 1987). Am. J. Obstet. Gynecol. 166(5):1992 (May);1482-1485.
6. Hewitt J. Histologic criteria for lichen sclerosus of the vulva. J. Reprod. Med. 31(9):1986 (Sep);781-787.
7. Hsu S.M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29(4):1981 (Apr);577-580.
8. Soini Y., Hurskainen T., Hoyhtya M., Oikarinen A., Autio-Harmainen H. 72 KD and 92 KD type IV collagenase, type IV collagen, and laminin mRNAs in breast cancer: a study by in situ hybridization. J. Histochem. Cytochem. 42(7):1994 (Jul);945-951.
9. Nikkari S.T., Hoyhtya M., Isola J., Nikkari T. Macrophages contain 92-kd gelatinase (MMP-9) at the site of degenerated internal elastic lamina in temporal arteritis. Am. J. Pathol. 149(5):1996 (Nov);1427-1433.
10. Mood A.M., Graybill F.A., Boes D. Introduction to the theory of statitist. 1974;McGraw-Hill, UK.
11. Barsky S.H., Siegal G.P., Jannotta F., Liotta L.A. Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab. Invest. 49(2):1983 (Aug);140-147.
12. Liotta L.A., Tryggvason K., Garbisa S., Hart I., Foltz C.M., Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature. 284(5751):1980 (Mar 6);67-68.
13. Monteagudo C., Merino M.J., San-Juan J., Liotta L.A., Stetler-Stevenson W.G. Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue. Am. J. Pathol. 136(3):1990 (Mar);585-592.
14. Talvensaari A., Apaja-Sarkkinen M., Hoyhtya M., Westerlund A., Puistola U., Turpeenniemi T. Matrix metalloproteinase 2 immunoreactive protein appears early in cervical epithelial dedifferentiation. Gynecol. Oncol. 72(3):1999 (Mar);306-311.
15. Soini Y., Alarakkola E., Autio-Harmainen H. Expression of messenger RNAs for metalloproteinases 2 and 9, type IV collagen, and laminin in nonneoplastic and neoplastic endometrium. Hum. Pathol. 28(2):1997 (Feb);220-226.
16. Carlson J.A., Ambros R., Malfetano J., Ross J., Grabowski R., Lamb P.et al. Vulvar lichen sclerosus and squamous cell carcinoma: a cohort, case control, and investigational study with historical perspective; implications for chronic inflammation and sclerosis in the development of neoplasia. Hum. Pathol. 29(9):1998 (Sep);932-948.
17. Tan S.H., Derrick E., McKee P.H., Hobbs C., Ridley M., Neill S. Altered p53 expression and epidermal cell proliferation is seen in vulval lichen sclerosus. J. Cutaneous Pathol. 21(4):1994 (Aug);316-323.
18. Mann P.R., Cowan M.A. Ultrastructural changes in four cases of lichen sclerosus et atrophicus. Br. J. Dermatol. 89(3):1973 (Sep);223-231.
19. Kint A., Geerts M.L. Lichen sclerosus et atrophicus: an electron microscopic study. J. Cutaneous Pathol. 2(1):1975;30-34.
20. Bancher-Todesca D., Obermair A., Bilgi S., Kohlberger P., Kainz C., Breitenecker G.et al. Angiogenesis in vulvar intraepithelial neoplasia. Gynecol. Oncol. 64(3):1997 (Mar);496-500.
21. Modesitt S.C., Waters A.B., Walton L., Fowler W.C. Jr., Van Le L. Vulvar intraepithelial neoplasia III: occult cancer and the impact of margin status on recurrence. Obstet. Gynecol. 92(6):1998 (Dec);962-966.
22. Ornstein D.L., Cohn K.H. Balance between activation and inhibition of matrix metalloproteinase-2 (MMP-2) is altered in colorectal tumors compared to normal colonic epithelium. Dig. Dis. Sci. 47(8):2002 (Aug);1821-1830.
23. Yoshizaki T., Sato H., Furukawa M. Recent advances in the regulation of matrix metalloproteinase 2 activation: from basic research to clinical implication (Review). Oncol. Rep. 9(3):2002 (May-Jun);607-611.
24. Garzetti G.G., Ciavattini A., Lucarini G., Goteri G., De Nictolis M., Biagini G. Microinvasive cervical carcinoma and cervical intraepithelial neoplasia: biologic significance and clinical implications of 72-kDa metalloproteinase immunostaining. Gynecol. Oncol. 61(2):1996 (May);197-203.
25. Davidson B., Goldberg I., Kopolovic J., Lerner-Geva L., Gotlieb W.H., Weis B.et al. Expression of matrix metalloproteinase-9 in squamous cell carcinoma of the uterine cervix-clinicopathologic study using immunohistochemistry and mRNA in situ hybridization. Gynecol. Oncol. 72(3):1999 (Mar);380-386.
26. Alvarez O.A., Carmichael D.F., DeClerck Y.A. Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases. J. Natl. Cancer Inst. 82(7):1990 (Apr 4);589-595.